00 Acta Scientific | International Open Library | Open Access Journals Publishing Group

Acta Scientific Biotechnology

Mini Review Volume 1 Issue 10

CRISPR Technology: A Potential Cure for HIV

Kartik Pal*

Amity University, India

*Corresponding Author: Kartik Pal, Amity University, India.

Received: September 04, 2020; Published: September 30, 2020

×

Abstract

  HIV is a virus that effects the immune system of the body which in turn increases the risk of attaining an infection and diseases. It has no cure till now however some treatment can help like antiretroviral drugs and an individual can lead a normal life not a healthy reproductive life. However, there are some cells which have a mutation CCR5-delta 32 which are immune to HIV virus. It was found in the bone marrow of a donor which was then transplanted in a patient known as “Berlin patient”. These cells show a great potential of curing HIV but still there are some rare cases in which the individual were infected by HIV virus although they had two copies of CCR5 mutant cells form each of patients. So, researchers used CRISPR technology to gene edit normal cells into CCR5 mutant cells and inserted in the patient body to cure HIV.

Keywords: CRISPR Technology; HIV; CCR5 Mutant Cells; CCR5-Delta 32

×

References

  1. Kritika Sharma and Abhishek Walia. “Human Immunodeficiency Virus (HIV)”. Acta Scientific Microbiology3 (2019): 24-26.
  2. Bharat S Parekh., et al. “Diagnosis of Human Immunodeficiency Virus Infection”. Clinical Microbiology Reviews 1 (2019).
  3. Fatima Barmania and Michael S Pepper. “C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection”. Applied and Translational Genomics 2 (2013): 3-16.
  4. Raja Chakraverty and Chowdhury M Hossain. “CRISPR and its Potential Scope in Molecular Biology and Medicine: An Appraisal”. Acta Scientific Pharmaceutical Sciences1 (2019): 17-22.
  5. Fuguo Jiang and Jennifer A Doudna. “CRISPR-Cas9 Structures and Mechanisms”. Annual Review of Biophysics 46 (2017): 505-529.
  6. Jonathan lambert. “Scientists use gene-edited stem cells to treat HIV - with mixed success”. Nature (2019).
  7. Sara reardon. “Gene edits to ‘CRISPR babies’ might have shortened their life expectancy”. Nature 7759 (2019): 16-17.
  8. Hirotaka Ebina., et al. “Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus”. Scientific Reports 3 (2013): 2510.
  9. Liao HK., et al. “Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells”. Nature Communications 6 (2015): 6413.
  10. Caroline S Binda., et al. “CRISPR-Cas9 Dual-gRNA attack causes mutation, excision and inversion of the HIV-1 Proviral DNA”. Viruses 3 (2020): 330.
  11. Chris Palmer. “Antiretroviral therapy combined with CRISPR gene editing can eliminate HIV infection in mice” (2020).
×

Citation

Citation: Kartik Pal. “CRISPR Technology: A Potential Cure for HIV". Acta Scientific Biotechnology 1.10 (2020): 18-23.




Metrics

Acceptance rate36%
Acceptance to publication20-30 days

Indexed In


News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is October 20, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US